---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-150301"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T15:36:59.413602+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics raises $5M upfront (up to $15M with warrant exercise) in equity offering

## Summary
- Upfront gross proceeds of $5.0M from sale of 423,372 shares (or pre-funded warrants) at $11.81 per share+private warrant.
- Additional up to $9.8M if private warrants (846,744 shares at $11.56) exercised fully; warrants expire 24 months after resale registration effective.
- Net proceeds ~$4.3M after placement agent fees (7% cash fee plus 6.5% on future warrant exercises).
- Proceeds to be used for working capital and potential clinical development/manufacturing of LYR-210 for chronic rhinosinusitis.
- Company previously terminated ~87 employees after failed ENLIGHTEN 1 Phase 3 trial and faces going concern risk.

## SEC filing metadata
- accession: 0001193125-25-150301
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312525150301/0001193125-25-150301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312525150301/d75821d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-150301
- JSON: https://secwatch.observer/filing/0001193125-25-150301.json
- Plain text: https://secwatch.observer/filing/0001193125-25-150301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.